TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
LQDA

Liquidia Technologies Inc

Healthcare · Drug Manufacturers - Specialty & Generic

67.50$ -1.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement LQDA
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
7.0% 4.4% 4.5% 10.0% 32.1% 23.5% 17.9% 16.5% 42.0% 8.4%
93.0% 95.6% 95.5% 90.0% 67.9% 76.5% 82.1% 83.5% 58.0% 91.6%
176.4% 341.1% 1,060.2% 501.6% 4,356.6% 159.6% 122.0% 247.3% 341.8% 24.8%
36.6% 140.7% 323.4% 168.4% 3,700.3% 179.8% 203.4% 255.8% 582.8% 99.3%
213.1% 481.8% 1,383.6% 670.1% 8,056.9% 339.4% 325.4% 503.1% 924.6% 124.1%
-120.0% -386.2% -1,288.1% -580.1% -7,989.0% -263.0% -243.3% -419.6% -866.6% -32.5%
0.6% 179.3% 701.5% 17.0% 116.0% 5.9% 14.7% 35.9% 89.2% 15.3%
-120.6% -401.7% -1,962.9% -589.5% -8,080.1% -269.0% -257.4% -448.9% -931.7% -43.5%
0.1% 179.3% 26.6% -14.8% -307.1% -37.3% -16.6% -12.5% – –
-120.6% -401.7% -1,962.9% -589.5% -8,080.1% -269.0% -257.4% -448.9% -931.7% -43.5%
-115.0% -209.6% -1,204.4% -537.9% -7,542.8% -219.4% -219.8% -400.6% -826.7% -27.3%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?